These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14631611)

  • 21. Selective exclusion of treatment arms in multi-arm randomized clinical trials.
    Law MG; Emery S
    Stat Med; 2003 Jan; 22(1):19-30. PubMed ID: 12486749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic beneficence and placebo controls.
    Ackerman TF
    Am J Bioeth; 2002; 2(2):21-2. PubMed ID: 12189065
    [No Abstract]   [Full Text] [Related]  

  • 23. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
    Hofmeijer J; Anema PC; van der Tweel I
    J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective trial design need not conflict with good patient care.
    Glass KC; Waring D
    Am J Bioeth; 2002; 2(2):25-6. PubMed ID: 12189068
    [No Abstract]   [Full Text] [Related]  

  • 26. Trial methodology and patient characteristics did not influence the size of placebo effects on pain.
    Kamper SJ; Machado LA; Herbert RD; Maher CG; McAuley JH
    J Clin Epidemiol; 2008 Mar; 61(3):256-60. PubMed ID: 18226748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-inferiority trials in surgical oncology.
    Fueglistaler P; Adamina M; Guller U
    Ann Surg Oncol; 2007 May; 14(5):1532-9. PubMed ID: 17294075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the design of phase II trials of cytostatic anticancer agents.
    Stone A; Wheeler C; Barge A
    Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Placebo in clinical research--a continual compromise between ethical requirements and scientific rigor].
    Saccà L
    Ann Ital Med Int; 2002; 17(4):215-20. PubMed ID: 12532559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The validity and ethics of giving placebo in a randomized nonpharmacologic trial was evaluated.
    Spigt MG; Knipschild PG; van Schayck CP; Knottnerus JA
    J Clin Epidemiol; 2005 Apr; 58(4):350-6. PubMed ID: 15862720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The placebo mystique: Implications for clinical trial methodology.
    Clifford V
    J Paediatr Child Health; 2011 Jun; 47(6):361-6. PubMed ID: 21309878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to ensure clinical trial sensitivity in psychotropic drug development: a case study.
    Videla S; Sust M; Fresquet A; Villoria J
    Clin Ther; 2005 Feb; 27(2):252-4. PubMed ID: 15811489
    [No Abstract]   [Full Text] [Related]  

  • 35. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How many do I need? Basic principles of sample size estimation.
    Devane D; Begley CM; Clarke M
    J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Debate about placebos points to issue surrounded by many shades of grey.
    Baer N
    CMAJ; 1996 Nov; 155(10):1475-6. PubMed ID: 8943938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study design in osteoporosis: a European perspective.
    Kanis JA; Alexandre JM; Bone HG; Abadie E; Brasseur D; Chassany O; Durrleman S; Lekkerkerker JF; Caulin F
    J Bone Miner Res; 2003 Jun; 18(6):1133-8. PubMed ID: 12817770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who's in control of the choice of control?
    Anderson JA
    Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199
    [No Abstract]   [Full Text] [Related]  

  • 40. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.